Stay updated with breaking news from Mark Bleackley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has completed the dosing stage in its Phase 1 anti-inflammatory drug trial. The early-stage study is...
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has presented its pre-Investigational New Drug Application (pre-IND) for traumatic brain injury and...
Dronabinol shows promise for the treatment of sleep apnea, and new advances from pharmaceutical companies show how it can be optimized.
Dronabinol shows promise for the treatment of sleep apnea, and new advances from pharmaceutical companies show how it can be optimized.
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has engaged leading contract research, development and manufacturing company Curia Global Inc to develop and...